Skip to content

Evidence based evaluation and target mechanism study of Pingwei Jianzhong Jiedu Formula in intervening in precancerous lesions of gastric cancer from the perspective of visceral rheumatism

Evidence based evaluation and target mechanism study of Pingwei Jianzhong Jiedu Formula in intervening in precancerous lesions of gastric cancer from the perspective of visceral rheumatism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025000182
Enrollment
Unknown
Registered
2025-01-25
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric precancerous lesions

Interventions

Pingwei Jianzhong Detoxification Formula Granules Group:no interventions

Sponsors

Guangzhou Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Patients who meet the diagnostic criteria (confirmed by pathology to have chronic atrophic gastritis possibly accompanied by intestinal metaplasia or dysplasia) and are informed and agree to receive treatment; 2) The patient is aged between 18 and 70 years old.

Exclusion criteria

Exclusion criteria: 1) Gastric mucosal cancer patients; 2) Patients with combined malignant tumors; 3) Individuals with other digestive system diseases; 4) Patients with severe heart lung liver kidney and other important organ diseases; 5) Pregnant or lactating women; 6) Has an impact on the patient's ability to self report serious brain or mental illnesses.

Design outcomes

Primary

MeasureTime frame
Conversion rate reduction;

Secondary

MeasureTime frame
Rheumatoid immune related detection indicators;Rheumatoid related symptom indicators;

Countries

China

Contacts

Public ContactXiaobo Yang

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

yangxiaobomd@163.com020-81887233-35841

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026